THE 2Î±-3Î²-6Î²-23-TETRAHYDRO-OLEAN-12-EN-28-OIC ACID FROM THE LEAVES OF CHRYSOBALANUS ICACO L. ATTENUATES THE INFLAMMATORY HYPERNOCICEPTION IN MICE
Objective: The species Chrysobalanus icaco L., popularly known as abajurÃº, abajeru, has frequently been associated with antiangiogenic, anti-inflammatory and antirheumatic effects. The 2Î±-3Î²-6Î²-23-tetrahydro-olean-12-en-28-oic acid (THOA) was isolated from the methanolic extract of Chrysobalanus icaco leaves. Thus, the aim of the study was to evaluate the antinociceptive and anti-inflammatory activities of THOA.
Methods: Acetic acid-induced abdominal writhing, formalin, von frey and open field tests were performed in mice. The number of writhes, licking time, mechanical threshold and walked squares by animals were the evaluation parameters applied, respectively. In addition, quantification of IL-1Î² and TNF-Î± were also performed. The THOA was administered orally at doses of 1â€“10 mg/kg in male mice. In addition, water, vehicle, morphine (5.01 mg/kg), acetylsalicylic acid (100 mg/kg), and dexamethasone (2.25 mg/kg) were administered.
Results: The THOA showed effect with 5 and 10 mg/kg in the acute pain induced by acetic acid (49% and 62% contortion inhibition), carrageenan (150% and 188% increase in mechanical threshold) and formalin (36% and 60% licking inhibition), respectively. These results indicate an inhibition of hyper nociception, while the reduction in the production of cytokines (TNF-Î± inhibitionâ€“64% and 88%; IL-1Î² inhibitionâ€“48% and 55%, respectively) confirmed the inflammatory inhibition by carrageenan. The THOA did not induce motor impairment. The THOA was not toxic after oral administration (LD50>50 mg/kg).
Conclusion: These data provide initial evidence that THOA decreases the inflammatory hyper nociception probably by inhibition of IL-1Î² and TNF-Î± production, proving to be effective in reducing pain and inflammation.
2. Hald A, Rono B, Lund LR, Egerod KL. LPS counter-regulates RNA expression of extracellular proteases and their inhibitors in murine macrophages. Mediators Inflammation 2012;15:78-94.
3. Nguyen MT, Chen A, Lu WJ, Fan W, Li PP, Ohda Y, et al. Regulation of chemokine and chemokine receptor expression by PPARgamma in adipocytes and macrophages. PLoS One 2012;7:49-76.
4. Khasar SG, McCarter G, Levine JD. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 1999;81:1104â€“12.
5. Verri Jr WA, Cunha TM, Parada CA, Wei XQ, Ferreira SH, Liew FY, et al. IL-15 mediates immune inflammatory hyper nociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci USA 2006;103:9721â€“5.
6. Obreja O, Rathee PK, Lips KS, Distler C, Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J 2002;16:1497â€“503.
7. Sarkar M, Biswas P, Samanta A. In vivo anti-inflammatory and in vitro antioxidant studies on a methanolic and aqueous extract of Leucas indica LINN. Asian J Pharm Clin Res 2013;6:284-90.
8. Silva IM, Peixoto AL. AbajurÃº (Chrysobalanus icaco L. and Eugenia rotundifolia Casar.) commercialized in Rio de Janeiro, Brazil. Braz J Pharmacog 2009;19:325-32.
9. Costa OA. Plantas hipoglicemiantes brasileiras II Leandra. Brasil: Leandra; 1977. p. 63â€“75.
10. Vargas-Simon G, Arellano-Ostoa G, Garcia-Villanueva E. Propagation by cuttings with leaves of icaco (Chrysobalanus icaco) and anatomy of the rooting. In: Proceedings of the International Society for Tropical Horticulture; 1997;41:264â€“9.
11. Paulo SA, Balassiano IT, Silva NH, Castilho RO, Kaplan MAC, Cabral MC, et al. Chrysobalanus icaco L. extract for antiangiogenic potential observation. Int J Mol Med 2000;5:667â€“9.
12. Li X, Joshi AS, El Sohly HN, Khan SI, Jacob MR, Zhang Z, et al. Fatty acid synthase inhibitors from plants: Isolation, structure elucidation, and SAR studies. J Nat Prod 2002;65:1909-14.
13. Collins DJ, Pilotti CA, Wallis AFA. Triterpene acids from some Papua new Guinea Terminalia species. Phytochemistry 1992;31:881-4.
14. Sahu NP, Roy SK, Mahato SB. Spectroscopic determination of structures of triterpenoid trisacchharides from Centella asiatica. Phytochemistry 1989;28:2852-4.
15. Guilhon CC, Raymundo LJRP, Alviano DS, Blank AF, Arrigoni-Blank MF, Matheus ME, et al. Characterisation of the anti-inflammatory and antinociceptive activities and the mechanism of the action of Lippia gracilis essential oil. J Ethnopharmacol 2011;135:406-13.
16. Koster R, Anderson M, De Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959;18:412.
17. Hunskaar S, Berge OG, Hole K. Dissociation between anti-nociceptive anti-inflammatory effects of acetylsalicylic and indomethacin in the formalin test. Pain 1986;25:125â€“32.
18. Cunha TM, Verri WAJR, Vivancos GG, Moreira IF, Reis S, Parada CA, et al. An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 2004;37:401-7.
19. Vigil SVG, De Liz R, Medeiros YS, FrÃ¶de TS. Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch. Transpl Immunol 2008;19:25â€“9.
20. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. The contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995;115:1265â€“75.
21. Barros HM, Tannhauser MA, Tannhauser SL, Tannhauser M. Enhanced detection of hyperactivity after drug withdrawal with a simple modification of the open-field apparatus. J Pharmacol Method 1991;26:269â€“75.
22. World Health Organization (WHO). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, WHO, Switzerland; 2000. p. 28-9.
23. The Organization of Economic Co-operation and Development (OECD). The OECD Guideline for Testing of Chemical: 420 Acute Oral Toxicity, OECD. France 2001;7:1-6.
24. Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol 1983;54:275â€“87.
25. Pradeepa K, Krishna V, Venkatesh, Santosh Kumar SR, Girish Kumar K. Antinociceptive property of leaves extract of Litsea glutinosa. Asian J Pharm Clin Res 2013;6:182-4.
26. Fukawa K, Kawano O, Hibi M, Misaki N, Ohba S, Hatanaka Y. A method for evaluating analgesic agents in rats. J Pharmacol Methods 1980;4:251â€“9.
27. Kusuhara H, Fukunari A, Matsuyuki H, Okumoto T. Principal involvement of cyclooxygenase-1-derived prostaglandins in the c-fos expression of the rat hindbrain following visceral stimulation with acetic acid. Mol Brain Res 1997;52:151â€“6.
28. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, et al. Involvement of resident macrophages and mast cells in the writing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000;387:111â€“8.
29. Duarte ID, Nakamura M, Ferreira SH. Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res 1988;21:341â€“433.
30. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;54:597â€“652.
31. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992;51:5â€“17.
32. Wheeler-Aceto H, Cowan A. Neurogenic and tissue-mediated components of formalin-induced oedema: evidence for supraspinal regulation. Agents Actions 1991;34:264â€“9.
33. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987;30:103â€“14.
34. Shibata M, Ohkubo T, Takahashi H, Inuki R. Modified formalin test: characteristic biphasic pain response. Pain 1989; 38:347â€“52.
35. Santos AR, Calixto JB. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Lett 1997;235:73â€“6.
36. Otuki MF, Lima FV, Malheiros A, Cechinel-Filho V, Delle MF, Yunes RA, et al. Evaluation of the antinociceptive action caused by ether fraction and a triterpene isolated from the resin of Protium kleinii. Life Sci 2001;69:2225â€“36.
37. Omote K, Hazama K, Kawamata T, Kawamata M, Nakayaka Y, Toriyabe M, et al. Peripheral nitric oxide in carrageenan-induced inflammation. Brain Res 2001;912:171â€“5.
38. Cury Y, Picolo G, Gutierrez VP, Ferreira SH. Pain and analgesia: the dual effect of nitric oxide in the nociceptive system. Nitric Oxide 2011;25:243-54.
39. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660â€“4.
40. Ferreira SH, Lorenzetti BB, Poole S. Bradykinin initiates cytokine mediated inflammatory hyperalgesia. Br J Pharmacol 1993;110:1227â€“31.
41. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia Neurosci Lett 2004;361:184-7.
42. Cunha TM, Verri WA JR, Silva JS, Poole S, Cunha FQ, Ferreira SH. A cascade of cytokines mediates mechanical inflammatory hyper nociception in mice. Proc Natl Acad Sci U S A 2005; 102:1755-60.
43. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms of tumor necrosis factor-Î± (TNF-Î±) hyperalgesia. Brain Res 1995;692:244-50.
44. Poole S, Cunha FC, Ferreira SH. Hyperalgesia from subcutaneous cytokines. In: Watkins LR, Maier SF. eds. Cytokines and Pain. BirkhÃ¤user: Basel 1999;42:59-87.
45. Girard D. Using the air pouch model for assessing in vivo inflammatory activity of nanoparticles. Int J Nanomed 2014;9:1105-9.